Vaccine Aids in Combating Covid 19 Pandemic

As the novel coronavirus, SARS-CoV-2, continues to wreak havoc all over the world, scientists and physicians from around the world are racing to find the best course of action for containing the virus and keeping its spread to the population under control. One of the most effective methods of reducing the risk of infection and spreading of the virus is the development of an effective vaccine that works to aid in combating the virus and its associated disease, Covid 19. With years of research and development ahead, scientific teams are forging ahead in the development of Covid 19 vaccines that are targeted to work directly at killing the Covid 19 virus and, in some cases, boosting the overall immunity to the virus and its associated characteristics.

What Exactly is a Vaccine?

A vaccine is a regulatory agent, often referred to as a prophylactic treatment, that is specifically created to aid in providing immunity against different types of viruses, bacteria, or other pathogens that are known to cause diseases. When administered as it is intended, a vaccine will stimulate the body’s natural immune system response, by introducing a copy of the virus or bacteria which, in effect, will start the body’s production of “preformulated” antibodies and related defense mechanisms that are designed to combat and destroy the virus. For the Covid 19 virus, the effort to develop a vaccine has spanned multiple borders and countries with the results of this initiative yielding an unexpected and speedy resolution.

Types of Vaccines for Covid 19

The primary focus of vaccine research for Covid 19 has led to the development of three distinct vaccine categories that have shown promise in combating the virus itself. These primary types are represented by the following:

• Live Attenuated Vaccines: One of the most common forms of vaccine development, live attenuated vaccines are created using a living organism, either virus or bacteria, that has been altered in a laboratory setting that is designed to create a non-harmful version of the virus or bacteria. This non-harmful version is then utilized within the vaccine to stimulate the immune system of the recipient, mimicking the same effects as an actual infection, which, in turn, creates the same antibody production without the associated risk of contracting the virus.

• Recombinant Vaccines: Also known as vector-based vaccines, this type of Covid 19 vaccine utilizes a harmless type of virus or bacteria that has been genetically reconstructed using the main components of the coronavirus. The result of this would be the replication of the primary proteins and toxins of the virus that are responsible for boosting the production of infection-fighting antibodies that can be adapted to fight against the Covid 19 virus.

• Protein-Based Vaccines: By introducing pieces of proteins that are derived from the Covid 19 virus, along with other components known to induce the body’s immune system protection mechanism, the frequency of antibody production will be increased and will remain constant over a longer period of time.

The Development of a Covid 19 Vaccine

The process of vaccine development for Covid 19 pathogens began in a feverish state of research and development shortly following the identification of the virus itself. With the assistance of a wide range of organizations and personnel from around the world, many of the heavy lifting regarding the architectural requirements of the vaccine were taken on by scientists who worked in perfect tandem to create a product that would seal the “weak points” that are associated with SARS-CoV-2.

These research teams set out with a sense of purpose and managed to localize their choice materials, with an understanding of what behaviors and characteristics would be necessary to combat the virus and those that would be responsible for the overall effectiveness of the vaccine itself. From the initial development of the coronavirus’ genetic coding, to the formulation of clinical processes that would be required in order to create a complete vaccine, the process has moved forward in what can only be described as a graceful disposition.

Testing and Compliance

The development of a complete vaccine that meets the regulatory requirements of the scientific community is not a simple task. Vaccines must pass through a specific type of testing process before they can be considered for “clinical use”. This process involves a few different steps that are specified and must be followed to ensure the safety and efficacy of the vaccine.

Phase 1: Trials and Early Research

The initial phase of vaccine development for a virus or bacteria of unknown origin and characteristics is the initial testing for toxicity, immunogenicity, as well as the security of the future vaccine in terms of how it interacts with both the human body and other elements within the environment, including animals and plants.

During this phase, the physiological responses of test subjects are monitored under the most precise of conditions to create the most accurate data sets regarding the efficacy of the vaccine. At the conclusion of this stage, the medical team collaborating on the project will formulate a conclusive understanding of the vaccine’s properties and suitability for clinical use.

Phase 2: Clinical Trials

Once the vaccine successfully passes through the first phase of its development, it is subjected to further testing within clinical trials. During this phase, only the highest caliber of volunteers will be accepted and the methods of testing become much more intense. Vaccines that pass this second phase of testing with show a greater propensity to inducing the desired protective response, in terms of the creation of antibodies, within the body and the immunization of the test subjects.

Phase 3: Regulatory and Public Trials

The previous two phases must both be successfully passed before the vaccine is ready to be manufactured and delivered to the public for use in fighting the Covid 19 pandemic. During this third stage, a greater percentage of the general population is made subject to receiving the vaccine and its associated characteristics. The results of this stage are used in order to “verify” the claims made for the vaccine’s effectiveness in cases of immunization and protection from the Covid 19 virus.

Manufacturing and Distribution

Upon its successful completion of the three main phases of the vaccine development process, the Covid 19 vaccine is then ready to be produced and distributed throughout the world. It is the intention of vaccine developers that the product is produced in a clean and hygienic environment and is designated with the appropriate labeling to distinguish it as an approved and clinically tested product. Once the vaccine is manufactured and is available on the market, it can then be dispatched to medical facilities throughout the world, where it can be used as the primary means of combating the Covid 19 virus.

The Benefits of a Covid 19 Vaccine

Covid 19 has had a devastating effect on the global community and the world in general. With hundreds of thousands of people dead or injured from Covid 19 infections, the need for a safe and effective course of action is paramount. There are a few significant benefits to a Covid 19 vaccine that should be deeply considered and appreciated.

• Improves Immunity: Vaccines heighten the body’s own resistance and immunity to the Covid 19 virus by introducing it in a more protective manner, allowing the body to create its own protective defenses against the virus.

• Enhances Vaccination: Vaccines act as a booster for further vaccinations against the virus, allowing for more doses to be used at later dates to ensure long-term protection against the virus.

• Reduces Spread: By lowering the infection rate of the virus, a Covid 19 vaccine will effectively work to stop the spread of the virus and reduce the potential for further outbreaks from occurring.

• Better Care & Treatment: With the vaccine reducing the potential of a severe Covid 19 infection, medical teams can provide better care for those who are infected with a greater focus on early prevention and diagnosis, rather than the after-effects of the underlying infection.

• Cost Effective: Vaccination is a cost effective way to protect against the Covid 19 virus, ultimately lowering the overall financial costs associated with treating the virus and providing a more economical means of preventing the virus from spreading.

Vaccines have been around since the late 18th century and have been primarily developed and utilized to combat infectious diseases. With the arrival of Covid 19, scientific researchers and medical teams the world over have developed a safe and effective vaccine to aid in combating the virus and work to help stop the spread of the virus before it causes further harm and destruction. The vaccine is safe and combines the efforts of many, from both the public and private sectors, all in the efforts of providing a viable form of protection against Covid 19. As the scientific world continues to advance in the technological advancements of vaccine research for other viruses and diseases, this Covid 19 initiative will, no doubt, remain as a strong example of the wonders that can be achieved through hard work and dedication.